Despite almost universal testing for human-epidermal-growth-factor-receptor-2 (HER2), many women with a HER2-positive cancer may not receive trastuzumab. Fewer women received the newer gene-expression-profile (GEP) test.
Centralized reminder/recall (R/R) is less costly to deliver than decentralized R/R for both children and adolescents when implemented for patients within an accountable care organization.
Evidence-based guidelines are needed to determine appropriate follow-up intervals for chronic medical conditions to maximize the quality of patient care and minimize unnecessary costs.
This paper describes the rationale and benefits of incorporating mental health into accountable care organizations using the Chronic Care Model.
This study examines variation among health plans in resource use and quality of care for patients with diabetes mellitus or cardiovascular disease.
The Medicare program’s transition in 2004 to tiered fee-for-service physician reimbursement for dialysis care had the unintended consequence of reducing use of home dialysis.
This study tested 3 financial incentives encouraging breast cancer screening (mammograms) among women deemed overdue. None were effective overall; "person-centered" incentives worked in the most recently screened subgroup.
We describe the Veterans Health Administration's nationwide patient-centered medical home (PCMH) initiative and evaluate interim changes in PCMH-related patient care processes.
The potential of nurse practitioners is not being fully realized in primary care medical practices. Consequently, cost and quality gains are not being achieved.
We find that under current regulatory and market conditions, demand for hospital-based emergency services is highly inelastic with respect to price, giving hospitals substantial pricing power over out-of-network emergency services.
We assessed Regional Extension Centers' (RECs') progress in promoting EHR adoption among providers in rural and health professional shortage areas and found that RECs are achieving much success in enrolling these providers.
The pioglitazone safety warning issued in South Korea, which recommended prescribing with careful attention among those with high risk of bladder cancer, led to a moderate decrease in pioglitazone users.
Examining the financial impact that patient assistance programs and the 340B Drug Pricing Program have on improving medication cost.
Racial disparities are widespread in healthcare. Disparities can have a strong influence on diabetes care. This manuscript explores the source of such disparities.
In this reply to the commentary, “A Call for a Statewide Medication Reconciliation Program,” published in the October 2016 issue of The American Journal of Managed Care®, authors discuss a proven and scalable solution to improve medication reconciliation that is already available to, and used by, clinicians.